Last reviewed · How we verify

NCT04772144

Nurse-led Smoking Cessation With Further Follow-up in Lifestyle Centres - a Randomized Pilot Study

Completed NA Last updated 18 October 2022
What this trial tests

NA trial testing behavioural and cessation aids in Smoking Cessation in 58 participants. Completed in 1 June 2022.

Timeline
25 February 2021
Primary endpoint
1 June 2022
1 June 2022

Quick facts

Lead sponsorVestre Viken Hospital Trust
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment58
Start date25 February 2021
Primary completion1 June 2022
Estimated completion1 June 2022
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Vestre Viken Hospital Trust

Who can join

18 and older, any sex, with Smoking Cessation or Smoking Behaviors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized controlled pilot study is to test whether an in-hospital nurse-led smoking cessation intervention increases the refferal rate to healty life-centers in the municipalities. We will also describe the proportion who succeed in quitting smoking between the intervention group and the control group and obtain new knowledge about the patient and system factors of importance for participation to healty life-centers and for successful and unsuccessful smoking cessation.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Barriers and facilitators for smoking cessation in chronic smokers with atherosclerotic cardiovascular disease enrolled in a randomized intervention trial: A qualitative study.
    Getz V, Munkhaugen J, Lie HC, Dammen T. · · 2023 · cited 7× · PMID 37034951 · DOI 10.3389/fpsyg.2023.1060701
  2. A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial.
    Pleym K, Dammen T, Wedon-Fekjaer H, Husebye E, et al · · 2024 · cited 1× · PMID 38666249 · DOI 10.1093/ehjopen/oeae028
  3. Clinical and psychosocial factors predicting persistent smoking in hospitalized patients with atherosclerotic vascular disease: A prespecified analysis of two randomized controlled trials.
    Getz V, Pleym K, Dammen T, Husebye E, et al · · 2026 · PMID 41869372 · DOI 10.18332/tpc/217328

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other Vestre Viken Hospital Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04772144.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing